State of Tennessee, Department of Treasury
CPRX

State of Tennessee, Department of Treasury’s Catalyst Pharmaceutical CPRX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
44,648
-464
-1% -$11.1K ﹤0.01% 1154
2025
Q4 		$1.1M Sell
45,112
-4,315
-9% -$96.1K ﹤0.01% 1159
2025
Q3 		$974K Buy
49,427
+560
+1% +$11.5K ﹤0.01% 1212
2025
Q2 		$1.06M Sell
48,867
-932
-2% -$22K ﹤0.01% 1141
2025
Q1 		$1.21M Sell
49,799
-788
-2% -$17.7K ﹤0.01% 1086
2024
Q4 		$1.06M Buy
50,587
+2,193
+5% +$47.1K ﹤0.01% 1175
2024
Q3 		$962K Sell
48,394
-2,196
-4% -$40.7K ﹤0.01% 1221
2024
Q2 		$784K Buy
50,590
+2,683
+6% +$41.8K ﹤0.01% 1255
2024
Q1 		$764K Sell
47,907
-7,224
-13% -$109K ﹤0.01% 1253
2023
Q4 		$927K Sell
55,131
-652
-1% -$8.91K ﹤0.01% 1221
2023
Q3 		$652K Sell
55,783
-2,060
-4% -$27.6K ﹤0.01% 1223
2023
Q2 		$777K Buy
57,843
+1,219
+2% +$17.5K ﹤0.01% 1262
2023
Q1 		$939K Buy
56,624
+292
+0.5% +$4.82K ﹤0.01% 1137
2022
Q4 		$1.05M Buy
56,332
+3,195
+6% +$49.2K ﹤0.01% 1108
2022
Q3 		$681K Buy
+53,137
New +$630K ﹤0.01% 1223

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State of Tennessee, Department of Treasury's CPRX Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its Catalyst Pharmaceutical (CPRX) stake by 1% in Q1 2026, selling an estimated $11.1K and leaving 44,648 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

State of Tennessee, Department of Treasury first reported a position in CPRX in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.21M in Q1 2025. 381 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • State of Tennessee, Department of Treasury held 44,648 shares of Catalyst Pharmaceutical worth $1.11M as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 464 Catalyst Pharmaceutical shares in Q1 2026, an estimated $11.1K.
  • Catalyst Pharmaceutical made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1154 holding.
  • State of Tennessee, Department of Treasury first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 15 quarters since.
  • State of Tennessee, Department of Treasury's Catalyst Pharmaceutical position peaked at $1.21M in Q1 2025.
  • 381 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.